Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 study to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis. The trial is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• BMS-986278

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING